Faster global financial news!
Rasonque
-
FDA approves Revolution Medicines' new pancreatic cancer drug daraxonrasib for market, the first targeted therapy, nearly doubling patients' median survival.
The U.S. Food and Drug Administration (FDA) has approved daraxonrasib (brand name Rasonque), a new pancreatic cancer drug from Revolution Medicines (RevMed), for market. This drug is the first targete
-
FDA approves Revolution Medicines' new pancreatic cancer drug daraxonrasib for market, the first targeted therapy, nearly doubling patients' median survival.
The U.S. Food and Drug Administration (FDA) has approved daraxonrasib (brand name Rasonque), a new pancreatic cancer drug from Revolution Medicines (RevMed), for market. This drug is the first targete
- No data
Rasonque
24H Trending
-
1
Robot baristas and K-pop dancers lead South Korea's physical AI boom
-
2
USDT Tether: Wallet Address Lookup and Official Wallet Usage Guide
-
3
2GIVE Coin Status Analysis: Extremely Low Market Activity, Investment Prospects Questioned
-
4
AltLayer (ALT) Project Analysis and Current Status
-
5
NGOT Analysis: Positioning, Total Supply, and Market Status
-
6
GXC Token Has Transformed into REI Network: Trading Status and REI Token Buying and Selling Guide
-
7
Goldman Sachs Strategists: Expect AI capital expenditure growth to slow in 2027, with earnings growth decelerating from 30% at that time.
-
8
London copper futures closed at $14,622 per ton on Friday, near historical highs; UBS reiterated its bullish stance, while JPMorgan Chase warned that strikes at Chilean copper mines could lead to production cuts.
-
9
CIRQ Coin Analysis: Distinguishing Cirquity Token from the Quantum Computing Framework
-
10
How is TFUEL performing? What are the future development prospects for TFUEL?
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
